SoCal.Startups is building the most comprehensive resource for Southern California's tech scene.
SoCal.Startups
Be an early user
ChromaCode, Inc. hero photo
ChromaCode, Inc. logo

ChromaCode, Inc.

Carlsbad, CA
LAST FUNDING
$3.8M

ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs, physicians, and patients to access actionable biomarkers faster and more affordably. With HDPCR™, you can get critical and complete data, analyzed with simplicity, without paying for excess information.

Funding history

RoundAmount
Undisclosed$3.8M
SEC Form D filed
Feb 5, 2025·Feb 27, 2023·Mar 3, 2022·Dec 3, 2020·Aug 16, 2019·Apr 16, 2019·Apr 25, 2017

About ChromaCode, Inc.

How much funding has ChromaCode, Inc. raised?

ChromaCode, Inc. has raised $3.8M in total funding.

Where is ChromaCode, Inc. headquartered?

ChromaCode, Inc. is headquartered in Carlsbad, CA.

What does ChromaCode, Inc. do?

ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs, physicians, and patients to access actionable biomarkers faster and more affordably. With HDPCR™, you can get critical and complete data, analyzed with simplicity, without paying for excess information.

What problem does ChromaCode, Inc. solve?

Physicians and lab partners need faster, more cost-effective access to critical genomic biomarkers to guide oncology and disease-management decisions than conventional testing methods allow.

What's ChromaCode, Inc.'s solution?

ChromaCode's HDPCR multiplexing platform pairs proprietary chemistry with cloud-based software (ChromaCode Cloud) to deliver multi-analyte genomic assays via reagent kits with automated interpretation, requiring no hardware or software install.

What makes ChromaCode, Inc. different?

The page cites specific performance claims versus conventional digital PCR: over 4X the multiplexing, under-24-hour turnaround, zero on-site hardware/software installation, and ≥80% margins for lab partners due to lower cost of goods and higher throughput; it also claims broad regulatory compliance (HIPAA, HITRUST, ISO 13485, GDPR).

What makes ChromaCode, Inc. notable?

Carlsbad-based molecular diagnostics company founded in 2012 by Alex Dickinson, Aditya Rajgopal and Greg Gosch; has raised roughly $50M including a Series C from Adjuvant Capital and existing investor Northpond Ventures.

Leadership

Executive Officer, Director
LinkedIn ↗
Justin Klein
Director
Aditya Rajagopal
Director
Industry
Healthcare
HQ
Carlsbad, CA
Raised
$3.8M
❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.

MLA
"ChromaCode, Inc.: Funding & Investors." SoCal.Startups, September 3, 2026, https://socalstartups.io/companies/chromacode-inc. Accessed September 29, 2026.
APA
SoCal.Startups. (2026). ChromaCode, Inc.: Funding & Investors. Retrieved September 29, 2026, from https://socalstartups.io/companies/chromacode-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=ChromaCode, Inc.: Funding & Investors |url=https://socalstartups.io/companies/chromacode-inc |website=SoCal.Startups |access-date=September 29, 2026}}
🏷 Embed this badge

Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.

ChromaCode, Inc. featured on SoCal.Startups
HTML
<a href="https://socalstartups.io/companies/chromacode-inc" target="_blank" rel="noopener"><img src="https://socalstartups.io/badge.svg" width="220" height="52" alt="ChromaCode, Inc. featured on SoCal.Startups" /></a>
MARKDOWN
[![ChromaCode, Inc. featured on SoCal.Startups](https://socalstartups.io/badge.svg)](https://socalstartups.io/companies/chromacode-inc)